115. The Future of Therapy Is Psychedelic

He’s a professor of computation and behavioral science at the University of Chicago, MacArthur “Genius Grant” recipient, and author. Steve and Sendhil laugh their way through a conversation about the importance of play, the benefits of change, and why we remember so little about ...  Show more

In this interview, Steve talks with the former top adviser to presidents Clinton and Obama, about his record — and his reputation. And Rahm explains that while he believes in the power of the federal government, as former mayor of Chicago, he says that cities are where problems r ...  Show more

Rick Doblin, psychotherapist and the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS), returns to chat about methylenedioxymethamphetamine (MDMA) and its positive effects on PTSD and trauma.Today, Doblin share what MDMA is, how it ...  Show more

Could psychedelics help us heal from trauma and mental illnesses? Researcher Rick Doblin has spent the past three decades investigating this question, and the results are promising. In this fascinating dive into the science of psychedelics, he explains how drugs like LSD, psilocy ...  Show more

In this episode, Rick Doblin, founder and executive director of MAPS, discusses MDMA, a molecule that has (at a minimum) revolutionary therapeutic benefits for PTSD, but arguably could have, at the highest order, a lasting impact on humanity's ability to peacefully coexist. Ri ...

In the ‘80s and ‘90s, MDMA (also known as molly or ecstasy) was dismissed as a club drug and became the target of anti-drug propaganda. Today, it’s on the brink of being legalized for use in clinical therapy to treat conditions like PTSD. How did that happen? And what have we lea ...  Show more